Slide Insurance (SLDE) CEO-linked entity sells 481,983 shares under 10b5-1 plan
Rhea-AI Filing Summary
Slide Insurance Holdings, Inc. director and CEO Bruce Lucas reported indirect open-market sales of common stock by IIM Holdings II, LLC, an entity he controls. IIM Holdings II, LLC sold 136,500 shares on April 27, 154,207 shares on April 28, and 191,276 shares on April 29, 2026, at weighted-average prices of $18.75, $18.94, and $19.24 per share, respectively, under a pre-arranged Rule 10b5-1 trading plan adopted on November 21, 2025.
Following these transactions, IIM Holdings II, LLC held 36,571,004 Slide Insurance shares. The filing also reports additional indirect holdings through the reporting person’s spouse, trusts, and a grantor retained annuity trust, as well as 1,137,546 shares held directly. A footnote states the spouse sold 47,668 shares between April 27–29, 2026 under a separate 10b5-1 trading plan.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 191,276 | $19.24 | $3.68M |
| Sale | Common Stock | 154,207 | $18.94 | $2.92M |
| Sale | Common Stock | 136,500 | $18.75 | $2.56M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 21, 2025. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.60 to $19.05 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. The securities reported herein are held by IIM Holdings II, LLC, which is an entity controlled by the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.75 to $19.15 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.77 to $19.78 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. Represent shares of common stock beneficially owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. The amount shown reflects the amount owned by the Reporting Person's spouse after the sale of 47,668 shares of common stock between April 27-29, 2026, pursuant to a 10b5-1 trading plan, at prices ranging from $18.60 to $19.78 per share. Represent shares of common stock beneficially owned by the Reporting Person's spouse through Securus Risk Management LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Represent shares held through the Emma Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Represent shares held through the Ava Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.